- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Ranibizumab antibody from the original Lucentis® and biosimilar commercial drugs.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
VEGF-A |
Monoclonal Antibody |
Lucentis® |
10 mg/mL |
– |
0.2 mg |
tba |
tba |
860,00 € |
||
VEGF-A |
Biosimilar , Monoclonal Antibody |
Ranivisio® |
10 mg/mL |
– |
0.2 mg |
tba |
tba |
1.190,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
